logo-loader

bit bio unveils new executive team following rebrand

Published: 10:30 04 Nov 2019 GMT

Horizon Discovery Group PLC - bit bio unveils new executive team following rebrand
Chief scientific adviser Roger Pedersen is a co-founder of the Cambridge Stem Cell Institute

bit bio has unveiled a new executive team following its rebranding from Elpis Biomed in October.

The biotech, which specialises in coding and reprogramming stem cells, is now headed by chief executive Mark Kotter, a stem cell biologist and neurosurgeon at the University of Cambridge, while Florian Schuster, the former finance boss of Tessa Therapeutics, is taking up the positions of chief financial and chief operations officer.

The firm’s chief business officer, meanwhile, is Paul Morrill, the co-founder of gene editing firm Horizon Discovery Group PLC (LON:HZD), with immune-oncology clinician Ramy Ibrahim and stem cell reprogramming specialist Marius Wernig serving as scientific advisors.

Ibrahim and Wernig join chief scientific adviser Roger Pedersen, a thought leader in stem cell biology and a co-founder of the Cambridge Stem Cell Institute.

The company is aiming to commercialise Opti-OX, a technology to efficiently and consistently reprogram human stem cells for research, drug discovery and cell therapy.

Full interview: Bit bio developing a technology platform 'capable of...

Bit bio's Mark Kotter speaks to Proactive London's Andrew Scott following the name change from Elpis Biomed. The business has recently hired a number of industry heavy-hitters to its leadership team as it works towards its goal of developing a scalable platform technology capable of producing...

on 6/11/19